Literature DB >> 21560130

Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.

Sheraz Khan1, Hannah Batchelor, Peter Hanson, Yvonne Perrie, Afzal R Mohammed.   

Abstract

Poor water solubility leads to low dissolution rate and consequently, it can limit bioavailability. Solid dispersions, where the drug is dispersed into an inert, hydrophilic polymer matrix can enhance drug dissolution. Solid dispersions were prepared using phenacetin and phenylbutazone as model drugs with polyethylene glycol (PEG) 8000 (carrier), by melt fusion method. Phenacetin and phenylbutazone displayed an increase in the dissolution rate when formulated as solid dispersions as compared with their physical mixture and drug alone counterparts. Characterisation of the solid dispersions was performed using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM). DSC studies revealed that drugs were present in the amorphous form within the solid dispersions. FTIR spectra for the solid dispersions of drugs suggested that there was a lack of interaction between PEG 8000 and the drug. However, the physical mixture of phenacetin with PEG 8000 indicated the formation of hydrogen bond between phenacetin and the carrier. Permeability of phenacetin and phenylbutazone was higher for solid dispersions as compared with that of drug alone across Caco-2 cell monolayers. Permeability studies have shown that both phenacetin and phenylbutazone, and their solid dispersions can be categorised as well-absorbed compounds.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Keywords:  DSC; Dissolution studies; FTIR; PEG 8000; Permeability; Phenacetin; Phenylbutazone; amorphous form; solid dispersions

Mesh:

Substances:

Year:  2011        PMID: 21560130     DOI: 10.1002/jps.22613

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).

Authors:  Christian Maass; Cynthia L Stokes; Linda G Griffith; Murat Cirit
Journal:  Integr Biol (Camb)       Date:  2017-04-18       Impact factor: 2.192

2.  Enhancing the dissolution of phenylbutazone using Syloid® based mesoporous silicas for oral equine applications.

Authors:  Laura J Waters; John P Hanrahan; Joseph M Tobin; Catherine V Finch; Gareth M B Parkes; Shamsuddeen A Ahmad; Faraj Mohammad; Maria Saleem
Journal:  J Pharm Anal       Date:  2018-01-31

3.  APTES-Modified SBA-15 as a Non-Toxic Carrier for Phenylbutazone.

Authors:  Adrianna Dadej; Aneta Woźniak-Braszak; Paweł Bilski; Hanna Piotrowska-Kempisty; Małgorzata Józkowiak; Maciej Stawny; Daniela Dadej; Michał Mrotek; Anna Jelińska
Journal:  Materials (Basel)       Date:  2022-01-26       Impact factor: 3.623

4.  Pharmaceutical development and optimization of azithromycin suppository for paediatric use.

Authors:  Tina Kauss; Alexandra Gaubert; Chantal Boyer; Boubakar B Ba; Muriel Manse; Stephane Massip; Jean-Michel Léger; Fawaz Fawaz; Martine Lembege; Jean-Michel Boiron; Xavier Lafarge; Niklas Lindegardh; Nicholas J White; Piero Olliaro; Pascal Millet; Karen Gaudin
Journal:  Int J Pharm       Date:  2012-12-03       Impact factor: 5.875

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.